← Open Payments lookup

LESLIE MCCOLLUM: Open Payments

NPI 1710115506 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$630 in 24 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $543 · 2025 $630

Food & beverage: $630
CompanyPaymentsAmount
Janssen Biotech, Inc.6$178
Madrigal Pharmaceuticals2$117
Lilly USA, LLC3$62
GENZYME CORPORATION2$47
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$38
Daiichi Sankyo Inc.1$27
Sandoz Inc.1$24
Gilead Sciences, Inc.1$22
QOL Medical, LLC1$22
Takeda Pharmaceuticals U.S.A., Inc.1$22

Products named: TREMFYA, REZDIFFRA, OMVOH, DUPIXENT, XIFAXAN, INJECTAFER, HYRIMOZ, Sucraid.

Industry payments across MS — which companies pay providers there.